arrow
J

Jonathan Maher

roche holding usa
H指数:39
被引数:5,416

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery of Clinical Candidate GDC-8264, a Novel, Potent and Selective RIP1 Inhibitor for Amelioration of Tissue Damage and the Treatment of Inflammatory Diseases
2025-10-010
PRE
Establishment of baseline profiles of 50 bile acids in preclinical toxicity species: A comprehensive assessment of translational differences and study design considerations for biomarker development

建立临床前毒性物种中50种胆汁酸的基线谱: 生物标志物开发的翻译差异和研究设计考虑因素的综合评估

2022-05-013
OAAI
Discovery of Acyl-sulfonamide Nav1.7 Inhibitors GDC-0276 and GDC-0310
2021-03-0822
PREAI
Selective, chemically-induced degradation of BRM (SMARCA2) enables in vivo efficacy in BRG1 (SMARCA4)-deficient xenograft tumor models
2020-08-150
PRE
Discovery of Potent Benzolactam IRAK4 Inhibitors with Robust in Vivo Activity

发现具有强大体内活性的强效苯并内酰胺IRAK4抑制剂

2019-11-1119
OAAI
Development of Potent and Selective Pyrazolopyrimidine IRAK4 Inhibitors
2019-05-1323
OAAI
Structure- and Ligand-Based Discovery of Chromane Arylsulfonamide Nav1.7 Inhibitors for the Treatment of Chronic Pain
2019-04-0325
PREAI
Can Bile Salt Export Pump Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? An International Transporter Consortium Perspective
2018-10-2284
OAAI
A Unique Approach to Design Potent and Selective Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP) Inhibitors
2017-12-1124
PREAI
GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP)
2017-09-2199
PREAI
Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300
2016-09-2883
PREAI